share_log

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DaVita公司安排于2024年第二季度进行投资者电话会议看涨
德维特 ·  07/18 00:00

DENVER, July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

德维特公司(NYSE:DVA)于2024年7月18日宣布,该公司计划于2024年8月6日(星期二)下午5点东部时间举行季度电话会议,以讨论第二季度的业绩。该公司计划在同一天市场收盘后公布其结果。

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

这次电话会议也将通过DaVita投资者关系网页进行网络直播,您可以按以下方式参加此次电话会议:

Tuesday, August 6, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042

2024年8月6日,星期二
电话会议将于美国东部时间下午5点开始。
可通过此链接访问网络直播。
拨入电话号码:877-918-6630。
国际拨入电话号码:517-308-9042。

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

在致电时,请向运营商提供密码“Earnings”,并提供您的姓名和公司名称。无法听取电话会议的投资者将能够通过我们的网站investors.davita.com访问重播。不提供电话重播。

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2024, DaVita served approximately 258,600 patients at 3,092 outpatient dialysis centers, of which 2,665 centers were located in the United States and 427 centers were located in 12 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

关于德维特公司
DaVita(NYSE:DVA)是一家专注于改进全球患者的生命质量的医疗保健服务提供商。该公司是美国最大的肾脏护理服务提供商之一,并在临床质量和创新方面担当领导者已经超过20年。DaVita在慢性肾脏病的每个阶段和环节为患者提供护理,从减缓肾脏疾病的进展到帮助支持移植,从急性医院护理到居家透析。截至2024年3月31日,DaVita在3092个门诊透析中心为约258,600名患者提供护理,其中2665个中心位于美国,另外427个中心位于全球12个其他国家。DaVita减少了住院、提高了患者的生存率,并协作推动肾脏护理行业采用公平和高质量的护理标准,使每个患者在任何地方都能得到最好的护理。欲了解更多信息,请访问DaVita.com/About。

Contact Information
Investors:
IR@davita.com

联系信息
投资者:
IR@davita.com

big

SOURCE DaVita

SOURCE 德维特

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发